WHO | Influenza vaccine (seasonal) - inactivated (10 dose vial)

Immunization standards

Influenza vaccine (seasonal) - inactivated (10 dose vial)

Vaccine Trade Name: Vaxigrip

Vaccine Type: Seasonal Influenza, split virion, inactivated

Manufacturer: Sanofi Pasteur

Country of Manufacture: France

Date of prequalification: 30 June 2011

NRA of Record: ANSM

Product Description

Pharmaceutical form: liquid

Presentation: 10 dose vial

Route of administration: intramuscular or deep subcutaneous

Vaccine Vial Monitor: Type 7

Shelf life: 12 months at 2 - 8°C

Secondary Packaging: carton of 10 vials

Cold Chain volume per dose (cm3): 2.38

Preservative: Thiomersal, 2 mcg/dose.

Handling of opened multi-dose vials: WHO recommends that opened vials of the vaccine may be kept for use in subsequent immunisation sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement:The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met


In September 2015, preservative efficacy in this vaccine was evaluated against the criteria indicated in the document WHO Assessing the programmatic suitability of vaccine candidates for WHO prequalification (Revision 2014)

Based on this evaluation, the recommendation regarding handling of opened multidose vials has been updated as indicated above. Please note that the previous recommendation is still indicated in the product insert (PI) published on this site. The manufacturer has indicated that an updated PI will be made available as soon as possible and will be published here when available.

Last update:

9 October 2015 11:41 CEST